-
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
18 Apr 2024 21:55 GMT
… clinical trial approval by the Philippine Food and Drug Administration … patients."
The Phase I clinical trial for YS-HBV-002 … and results of all clinical trials, YS Biopharma… ;ys-biopharma-granted-phase-i-clinical-trial-license-of-therapeutic-chronic …
-
GV20 Therapeutics Announces Clinical Trial Collaboration to Evaluate GV20-0251, a First-in-Class Antagonist Antibody Against the Novel Immune Checkpoint IGSF8, in Combination with KEYTRUDA® (pembrolizumab)
18 Apr 2024 20:59 GMT
… escalation and dose-expansion Phase I clinical trial testing GV20-0251 in … to identify novel drug targets and create … a multi-center Phase I clinical trial in patients with advanced … ;gv20-therapeutics-announces-clinical-trial-collaboration-to-evaluate-gv20 …
-
Virtual Clinical Trials Market Revenue, Size, Share Report, 2030
18 Apr 2024 13:10 GMT
… way to streamline the drug development process, reduce … Clinical Trials Market Segmentation:
➤ By Study Type
Interventional
Observational
Others
➤ By Phase
Phase 1 … of virtual clinical trial approaches.
Buy Virtual Clinical Trials Market report: …
-
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
18 Apr 2024 13:00 GMT
… ONCT-534 program. The drug has been well tolerated so … 534 have been assessed in Phase 1, Phase 2 will commence … medical need. Oncternal pursues drug development targeting promising, yet … of clinical trials; the risk that interim results of a clinical trial do …
-
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
18 Apr 2024 11:00 GMT
… portion of its Phase 1/1b clinical trial of BP1002 evaluating … a drug product modification of prexigebersen, is in a Phase 1… results from later stage clinical trials with much larger … consistent with earlier stage clinical trials, the maintenance of …
-
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
18 Apr 2024 11:00 GMT
… SOL-1 trial, and a Phase 1 clinical trial for the treatment of NPDR … launch of its first commercial drug product, DEXTENZA®, an FDA-approved … clinical trials will be predictive of the data of later clinical trials, particularly later clinical trials …
-
NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
18 Apr 2024 20:05 GMT
… Company’s recently completed Phase 1 clinical trial of SNK01, autologous … & Parkinson’s Drug Development Summit to be … ’s recently completed Phase 1 clinical trial evaluating autologous SNK01 … concluded. Previously disclosed Phase 1 data on the positive …
-
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
18 Apr 2024 07:34 GMT
… currently in Phase I clinical trials that has promising preclinical data. The drug was shown … was studied in a multicenter phase 1 trial, AMPLIFY-201 (NCT04853017 … trial (NCT05673811). Furthermore, a phase I clinical trial is currently recruiting for the …
-
Aspen Neuroscience Announces First Patient Dosed in First-in-Human Phase 1/2a Clinical Trial of Autologous Neuronal Cell Replacement Therapy for Parkinson's Disease
17 Apr 2024 17:19 GMT
…
Aspen Neuroscience Launches Groundbreaking Clinical Trial in Parkinson's … an open-label Phase 1/2a clinical trial to assess the … do not require immunosuppressive drugs to counteract the body… in-human-phase-12a-clinical-trial-of-autologous-neuronal- …
-
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
17 Apr 2024 12:52 GMT
… adverse events observed
Initiation of clinical trials in CNS diseases expected beginning … in-class potential.”
In this Phase 1 clinical trial, VENT-02 was well-tolerated … neurology disorders. Using its proprietary drug discovery platform, ReSOLVE™, the company …